期刊文献+

干燥综合征相关性细胞因子 被引量:13

下载PDF
导出
摘要 干燥综合征(SS)是一种慢性全身性炎症性自身免疫病,主要侵犯泪腺、唾液腺等外分泌腺。近年来,细胞因子在干燥综合征的发生发展中所起的作用引起了关注。Th1/Th2失衡抑制免疫细胞的凋亡,使细胞内累积大量免疫原性核小体,刺激T细胞产生自身抗体,加重自身免疫反应。Th17/Treg失衡可能诱发或加剧SS的发生发展。B细胞反应性增生产生大量细胞因子、免疫球蛋白及多种自身抗体,导致局部组织炎症损伤。SS患者唾液腺及血清中B细胞活化因子(BAFF)水平均较高,并与炎症活动及损害程度相关。趋化因子及其受体在SS炎性细胞迁移至病灶腺体及促进异位生发中心形成的过程中起重要作用。
作者 许满秀 钱先
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第2期206-208,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81273714) 江苏省自然科学基金(BK201187)
  • 相关文献

参考文献26

  • 1Stott DI,Hiepe F,Hummel M,et a1. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease.The salivary glands of patients with Sjǒgren's syndrome[J].{H}Journal of Clinical Investigation,1998,(5):938-946.
  • 2吴晓梅,黄雨梅,王兰兰,刘瑾.干燥综合征患者的泪腺及血浆中的白介素2、白介素6及其受体的研究[J].华西医科大学学报,2000,31(4):543-544. 被引量:6
  • 3Kawanami T,Sawaki T,Sakai T. Skewed Production of IL-6 and TGFβby cultured salivary gland epithelial cells from patients with Sjǒgren's syndrome[J].PLoS One,2012,(10):e45689.
  • 4丁大成,董怡,李申德,李小春,杨晓洁,甘晓丹.干燥综合征病人小涎腺中细胞因子的表达[J].中华医学杂志,1996,76(6):427-430. 被引量:5
  • 5Qin B,Wang J,Liang Y. The association between TNF-α,IL-10 gene polymorphisms and primary Sjǒgren's syndrome:A Meta-analysis and systemic review[J].PLoS One,2013,(5):e63401.
  • 6Yoshimura A,Wakabayashi Y,Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta[J].{H}Journal of Biochemistry,2010,(6):781-792.
  • 7Hsu HC,Yang P,Wang J. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice[J].{H}Nature Immunology,2008,(2):166-175.
  • 8Hillion S,Dueymes M,Youinou P. IL-6 contributes to the expression of RAGs in human mature B cells[J].{H}Journal of Immunology,2007,(10):6790-6798.
  • 9马英淳,吴敏,陈志伟.干燥综合征患者血清BAFF水平及调节[J].交通医学,2009,23(6):659-660. 被引量:4
  • 10葛琳,张华东,姜泉,路洁,殷海波,徐世杰,陈祎,孔丽.路氏滋燥汤对干燥综合征小鼠颌下腺细胞因子IFN-γ、IL-10的影响[J].世界中西医结合杂志,2011,6(1):28-30. 被引量:12

二级参考文献47

  • 1林华鹏,庄俊汉.干燥综合征发病机制研究进展[J].中国老年保健医学,2007,5(2):36-37. 被引量:10
  • 2Vieweg J, Jackson A. Modulation of antitumor responses by dendritic cells[J]. Springer SeminImmun, 2005, 26(3):329- 341.
  • 3Stohl W, Metyas S, Tan SM, et al. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2004, 63(9): 1096-1103.
  • 4Vitali C, Bombardieri S, Jonsson R, et al. Classication criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002,61(6): 554-558.
  • 5Ng LG, Sutherland AP, Newton R, et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF CO-stimulation of T and B cells[J]. J Immunol, 2004, 173(2): 807-817.
  • 6Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/ BLyS overexpression and ahered B cell differentiation with Sjogren's syndrome[J]. J ClinInvest, 2002, 109(1): 59-68.
  • 7Christopher E Collins, Amanda L Gavin, Thi-Sau Migone, et al. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels[J]. Arthritis Res Ther, 2006, 8(1): R6.
  • 8Zhou L, Zhong R, Hao W, et al.Interleukin-10 and interferon-3, up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells [J]. Exp Mol Pathol, 2009,87(1):54-58.
  • 9Fox RI,Carstens SA,Fong S,et al.Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjogren′s syndrome[J].Arthritis Rheum,1982,25(4):419.
  • 10Kuchroo VK,Das MP,Brown JA,et al.B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways:Application to autoimmune disease therapy[J].Cell,1995,80(5):707-718.

共引文献46

同被引文献133

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:463
  • 2林华鹏,庄俊汉.干燥综合征发病机制研究进展[J].中国老年保健医学,2007,5(2):36-37. 被引量:10
  • 3张旻,周新.结缔组织疾病继发间质性肺疾病的治疗进展[J].世界临床药物,2013,34(1):7-1. 被引量:2
  • 4蒋雪,曾昭淳.吲哚胺2,3-二加氧酶与肿瘤的免疫耐受[J].生命的化学,2005,25(4):322-324. 被引量:2
  • 5边莉,郭子宽,艾辉胜.肝细胞生长因子与免疫调控[J].中国实验血液学杂志,2007,15(2):441-444. 被引量:6
  • 6Xu DP, Fu JL, Jin L, et al. Circulating and liver resident CD4^+ CD25^+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B [ J ]. J Immunol, 2006, 177 ( 1 ) : 739 - 747.
  • 7Eastaff-Leung N, Mabarraek N, Barbour A, et al. Foxp3 + regulatory T cells, Th17 effeetor cells, and cytokine environment in inflammatory bowel disease[ J]. J Clin Immunol, 2010, 30 (1) : 80- 89.
  • 8Lina C, Conghua W, Nan L, et al. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis[J]. J Clin Immunol, 2011,31 (4) : 596 -605.
  • 9Niu YH, Liu HL, Yin DL, et al. The balance between intrahepatic IL-17^+ T ceils and Foxp3^+ regulatory T calls plays an important role in HBV-related end-stage liver disease [ J ]. BMC Immunol, 2011, 12(47) : 1471 -1479.
  • 10Hao C, Wang J, Kang W, et al. Kinetics of Th17 eytokines during telbivudine therapy in patients with chronic hepatitis B [ J ]. Viral Immunol, 2013, 26(5): 336-342.

引证文献13

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部